Pain Management and Opioid Prescribing

Members & Publications

During the public health emergency (PHE), the Drug Enforcement Administration (DEA) adopted policies providing flexibility for physicians managing patients with pain and opioid use disorder. These flexibilities allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients. The policies remain in effect for the duration of the PHE, unless DEA specifies an earlier date.

This flowchart from the DEA describes how to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency.

Resources for managing pain and prescribing opioids during the COVID-19 PHE and subsequent surges (please note that not all documents are formally endorsed by the Academy:


If you can't find what you need or would like additional support, we're here to help. Contact us at (847) 737-6000 or email

*Note: For all content created by Hart Health Strategies, a Washington D.C.-based firm that provides federal regulatory/quality advocacy support services to complement initiatives and efforts of AAPM&R. The views expressed do not necessarily reflect the views of AAPM&R.